CVM Cel Sci Corp

Price (delayed)

$1.01

Market cap

$8.58M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.22

Enterprise value

$12.87M

?
Relative Growth: Rel. Growth: 23
Relative Strength: Rel. Strength: 0
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 7

CEL-SCI believes that boosting a patient’s immune system while it is still intact should provide the greatest possible impact on survival. Therefore, in the Phase 3 study CEL-SCI treated patients ...

Highlights
The company's EPS has surged by 82% YoY and by 41% QoQ
CVM's debt is down by 19% year-on-year and by 7% since the previous quarter
Cel Sci's quick ratio has decreased by 49% from the previous quarter but it has increased by 14% YoY
The equity has decreased by 38% from the previous quarter and by 14% YoY

Key stats

What are the main financial stats of CVM

CVM stock price

How has the Cel Sci stock price performed over time
Intraday
-2.88%
1 week
0%
1 month
-28.87%
1 year
-60.39%
YTD
-80.8%
QTD
-68.54%

Financial performance

How have Cel Sci's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$22.24M
Net income
-$22.7M
Gross margin
N/A
Net margin
N/A
CVM's net income is up by 17% year-on-year and by 4.6% since the previous quarter
Cel Sci's operating income has increased by 15% YoY and by 4.5% from the previous quarter

Price vs fundamentals

How does CVM's price correlate with its fundamentals

Growth

What is Cel Sci's growth rate over time

Valuation

What is Cel Sci stock price valuation
P/E
N/A
P/B
1.24
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS has surged by 82% YoY and by 41% QoQ
The stock's price to book (P/B) is 75% less than its 5-year quarterly average of 5.1 and 60% less than its last 4 quarters average of 3.2
The equity has decreased by 38% from the previous quarter and by 14% YoY

Efficiency

How efficient is Cel Sci business performance
CVM's return on equity is up by 17% year-on-year and by 2% since the previous quarter
Cel Sci's return on invested capital has decreased by 13% YoY and by 2.3% QoQ
The return on assets has grown by 8% year-on-year

Dividends

What is CVM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CVM.

Financial health

How did Cel Sci financials performed over time
The total assets is 63% more than the total liabilities
Cel Sci's current ratio has plunged by 57% from the previous quarter but it has increased by 9% YoY
Cel Sci's quick ratio has decreased by 49% from the previous quarter but it has increased by 14% YoY
CVM's debt is 24% greater than its equity
The company's debt to equity has surged by 51% QoQ but it fell by 6% YoY
The equity has decreased by 38% from the previous quarter and by 14% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.